Multiunit floating drug delivery system of rosiglitazone maleate: Development, characterization, statistical optimization of drug release and in vivo evaluation

AAPS PharmSciTech

Volumn 10, Issue 3, 2009, Pages 887-899

  Mohan Kamila, Madan ^a   Mondal, Nita ^a   Kanta Ghosh, Lakshmi ^a   Kumar Gupta, Bijan ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

In vivo; Microsphere; Mixture design; Optimization; Rosiglitazone maleate

Indexed keywords

EUDRAGIT; FLOATING MICROSPHERE; MICROSPHERE; ROSIGLITAZONE; SOLVENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CRYSTALLIZATION; DIABETES MELLITUS; DRUG EFFICACY; DRUG FORMULATION; DRUG INCOMPATIBILITY; DRUG RESEARCH; DRUG SOLUBILITY; DRUG STRUCTURE; EMULSION; EVAPORATION; EXCIPIENT COMPATIBILITY; GLYCEMIC CONTROL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROENCAPSULATION; MOLECULAR DYNAMICS; MORNING DOSAGE; NONHUMAN; PARTICLE SIZE; PROCESS OPTIMIZATION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; GASTROINTESTINAL TRACT; HYPOGLYCEMIC AGENTS; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; NANOPARTICLES; PARTICLE SIZE; RATS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STOMACH; SURFACE PROPERTIES; THIAZOLIDINEDIONES; X-RAY DIFFRACTION;

EID: 70449521176     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9276-4     Document Type: Article

References (47)

1. PK Choudhury M Kar CS Chauhan 2008 Cellulose acetate microspheres as floating depot systems to increase gastric retention of antidiabetic drug: formulation, characterization and in vitro-in vivo evaluation Drug Dev Ind Pharm 34 349 54 18401776 10.1080/03639040701542531 1:CAS:528:DC%2BD1cXksVaiurk%3D
2. AA Deshpande NH Shah CT Rhodes W Malick 1997 Development of a novel controlled-release system for gastric retention Pharm Res 10 14815 9
3. JH Lee TG Park HK Choi 1999 Development of oral drug delivery system using floating microspheres J Microencapsul 16 715 29 10575624 10.1080/026520499288663 1:CAS:528:DyaK1MXmvFehu7s%3D (Pubitemid 29478951)
4. Rednick B, Tucker SJ. Sustained release bolus for animal husbandry. United States Patent US 3507952; 1970, Apr 21.
5. Urquhart J, Theeuwes F. Drug delivery system comprising a reservoir containing a plurality of tiny pills. United States Patent US 4434153; 1984, Feb 28.
6. Mamajek RC, Moyer ES. Drug-dispensing device and method. United States Patent US 4207890; 1980, June 17.
7. JA Fix R Cargill K Engle 1993 Controlled gastric emptying III: gastric residence time of a non-disintegrating geometric shape in human volunteers Pharm Res 10 1087 9 8378252 10.1023/A:1018939512213 1:STN:280:DyaK3szptFarug%3D%3D (Pubitemid 23211437)
8. J Fujimori Y Machida T Nagai 1994 Preparation of magnetically-responsive tablet and confirmation of its gastric residence in beagle dogs STP Pharm Sci 4 425 30 1:CAS:528:DyaK2MXjsF2rtr0%3D
9. AO Nur JS Zhang 2000 Captopril floating and/bioadhesive tablets: design and release kinetics Drug Dev Ind Pharm 26 965 9 10914320 10.1081/DDC-100101323 1:CAS:528:DC%2BD3cXkvFCgsbw%3D (Pubitemid 30471042)
10. A Streubel J Siepmann R Bodmeier 2003 Floating matrix tablets based on low density foam powder: effect of formulation and processing parameters on drug release Eur J Pharm Sci 18 37 45 12554071 10.1016/S0928-0987(02)00223-3 1:CAS:528:DC%2BD3sXmsFWjug%3D%3D (Pubitemid 36120553)
11. M Acikgoz HS Kas Z Hascelik U Milli AA Hincal 1995 Chitosan microspheres of diclofenac sodium, II: in vitro and in vivo evaluation Pharmazie 50 275 7 7792304 1:CAS:528:DyaK2MXlsl2ksLY%3D
12. V Iannuccelli G Coppi MT Bernabei R Cameroni 1998 Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study Int J Pharm 174 47 54 10.1016/S0378-5173(98)00229-4 1:CAS:528:DyaK1cXmsFGntb8%3D (Pubitemid 28486988)
13. AJ Wagstaff KL Goa 2002 Rosiglitazone-a review of its use in the management of type 2 diabetes mellitus Drugs 62 1805 37 12149047 10.2165/00003495-200262120-00007 1:CAS:528:DC%2BD38Xntl2ktr8%3D
14. ND Oakes CJ Kennedy AB Jenkins DR Laybutt DJ Chisholm EW Kraegen 1994 A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat Diabetes 43 1203 10 7926289 10.2337/diabetes.43.10.1203 1:CAS:528:DyaK2cXmslWrsbk%3D
15. SA Smith 1996 Peroxisomal proliferator activated receptors (PPARs): molecular targets for hypolipidaemic agents and insulin sensitisers Pharmacol Rev Com 8 57 64 1:CAS:528:DyaK2sXhtFSksb4%3D
16. PJ Cox DA Ryan FJ Hollis AM Harris AK Miller M Vousden H Cowley 2000 Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans Drug Metab Dispos 28 772 80 10859151 1:CAS:528:DC%2BD3cXks12isL4%3D
17. M Diamant RJ Heine 2003 Thiazolidinediones in type-II diabetes mellitus: current clinical evidence Drugs 63 1373 406 12825962 10.2165/00003495-200363130- 00004 1:CAS:528:DC%2BD3sXlvFels7Y%3D (Pubitemid 36776093)
18. I Idris S Gray R Donnelly 2003 Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability Diabetologia 46 288 90 12627329 1:CAS:528:DC%2BD3sXhvVyrurY%3D
19. AL Werner MT Travaglini 2001 A review of rosiglitazone in type 2 diabetes mellitus Pharmacotherapy 21 1082 99 11560198 10.1592/phco.21.13.1082.34615 1:CAS:528:DC%2BD3MXnt1Wgsbk%3D
20. LS Phillips G Grunberger E Miller R Patwardhan EB Rappaport A Salzman 2001 Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes Diabetes Care 24 308 15 11213884 10.2337/diacare.24.2.308 1:CAS:528:DC%2BD3MXhtlKhu7o%3D
21. SS Krishna S Ray RS Thakur 2006 Formulation and evaluation of mucoadhesive dosage form containing rosiglitazone maleate Pak J Pharm Sci 19 208 13 16935828 1:CAS:528:DC%2BD28XhtFSkt7%2FL
22. H Feng Z Wang D Chen 2002 Studies on rosiglitazone maleate intragastric floating sustained release tablet J China Pharm Univ 33 196 9 1:CAS:528:DC%2BD3sXjtVanuw%3D%3D
23. G Ponchel JM Irache 1998 Specific and non-specific bioadhesive particulate system for oral delivery to the gastrointestinal tract Adv Drug Del Rev 34 191 219 10.1016/S0169-409X(98)00040-4 1:CAS:528:DyaK1cXnsFWlt78%3D (Pubitemid 28535112)
24. M Bogataj A Mrhar A Kristl F Kozjek 1991 Eudragit E microspheres containing bacampicillin: preparation by solvent removal methods J Microencapsul 8 401 6 1941447 10.3109/02652049109069567 1:CAS:528:DyaK3MXmtFCksLo%3D
25. MM Kamila N Mondal LK Ghosh BK Gupta 2008 Drug dissolution studies and determination of rosiglitazone maleate in tablets and polymeric microspheres by a rapid, validated RP-HPLC method J Liq Chromatogr Rel Technol 31 2503 16 10.1080/10826070802319800 1:CAS:528:DC%2BD1cXhtVSku77P
26. VN Badri PA Thomas JK Pandit MG Kulkarni RA Mashelkar 1999 Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique J Control Release 58 9 20 10.1016/S0168-3659(98)00140-0 (Pubitemid 29371809)
27. PI Lee 1984 Novel zero order drug delivery via immobilized nonuniformed drug distribution in glassy hydrogels J Pharm Sci 73 1344 7 6502477 10.1002/jps.2600731004 1:CAS:528:DyaL2MXjt1SmtA%3D%3D
28. T Higuchi 1963 Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices J Pharm Sci 52 1145 9 14088963 10.1002/jps.2600521210 1:CAS:528:DyaF2cXlt1Whsg%3D%3D
29. Goodman LS, Hardman JG, Limbird LE, Gillman AG. Goodman and Gillman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001.
30. Armstrong NA, James KC. Pharmaceutical Experimental Design and Interpretation. London: Taylor & Francis; 1996.
31. Lewis GA, Mathieu D, Phan-Tan-Luu R. Pharmaceutical experimental design. New York: Marcel Dekker; 1999.
32. Bentley AO, Rawlins EA. Bentley's text book of pharmaceutics. 8th ed. London: Bailliere Tindall; 1977.
33. CY Wu LZ Benet 2005 Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system Pharm Res 22 11 23 15771225 10.1007/s11095-004-9004-4 1:CAS:528:DC%2BD2MXhtlCks70%3D (Pubitemid 40558141)
34. N Ma L Xu Q Wang X Zhang W Zhang Y Li, et al. 2008 Development and evaluation of new sustained-release floating microspheres Int J Pharm 358 82 90 18407442 10.1016/j.ijpharm.2008.02.024 1:CAS:528:DC%2BD1cXmsFagu78%3D
35. L Yin K Cheng G Wang L Zhang H Zang J Zhou 2008 Effect of film coating on cephalexin gastric-floating tablets J Chin Pharm Univ 39 37 41 1:CAS:528:DC%2BD1cXmtlOkuro%3D
36. R Lunio W Sawicki 2006 Influence of acrylic esters and methacrylic esters on flotation of pellets and release rate of verapamil hydrochloride Acta Pol Pharm 63 69 74 17515332 1:CAS:528:DC%2BD28XntV2hur4%3D
37. M Fukuda NA Peppas JW McGinity 2006 Floating hot-melt extruded tablets for gastroretentive controlled drug release system J Control Rel 115 121 9 10.1016/j.jconrel.2006.07.018 1:CAS:528:DC%2BD28XhtVOgt73E (Pubitemid 44537498)
38. A Streubel J Siepmann R Bodmeier 2003 Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles J Microencapsul 20 329 47 12881114 10.1080/0265204021000058384 1:CAS:528:DC%2BD3sXkvFCqsL0%3D (Pubitemid 36621475)
39. Avdeef A. Absorption and drug development: solubility, permeability, and charge state. Hoboken: Wiley; 2003. p. 91-3.
40. AA Zaghloul F Mustafa A Siddiqu M Khan 2005 Biodegradable microparticulates of beta-estradiol: preparation and in vitro characterization Drug Dev Ind Pharm 31 803 11 16221615 10.1080/03639040500217624 1:CAS:528:DC%2BD2MXhtV2gtb7O (Pubitemid 41356197)
41. Lehmann KOR. Chemistry and application properties of polymethacrylate coating systems. In: McGinity JW, editor. Aqueous polymeric coatings for pharmaceutical dosage forms. New York: Marcel Dekker; 1997. p. 101-76.
42. R Pignatello D Amico S Chiechio C Spadaro G Puglisi P Giunchedi 2001 Preparation and analgesic activity of Eudragit® RS100 microparticles containing diflunisal Drug Deliv 8 35 45 11280442 10.1080/107175401300002748 1:CAS:528:DC%2BD3MXhs1Oitbc%3D (Pubitemid 32179162)
43. N Bolourtchian K Karimi R Aboofazeli 2005 Preparation and characterization of ibuprofen microspheres J Microencapsul 22 529 38 16361196 10.1080/02652040500161941 1:CAS:528:DC%2BD2MXhtlWmur7E (Pubitemid 43123891)
44. S Bhattacharyya S Ray BK Gupta LK Ghosh 2007 Design, evaluation and statistical optimisation of a controlled release multiparticulate acyclovir delivery system Latin Am J Pharm 26 852 8 1:CAS:528:DC%2BD1cXjs1ejtr0%3D
45. CM Fernández YL Marín EG Fernández SI Pérez CB Jiménez 2008 Optimization of a meprobamate fast released tablet formulation using mixture design Latin Am J Pharm 27 62 7
46. J Plaizier-Vercammen D Dauwe P Brioen 1997 Possibility of the use of Eudragit® RS as a sustained release matrix agent for the incorporation of water soluble active compounds at high percentages STP Pharma Sci 7 491 7 1:CAS:528:DyaK1cXhsFajurk%3D
47. J Tillotson A Sakr 2004 Application of multiple-response optimization to fluoride release from an extended-release matrix tablet Pharm Ind 66 601 6 1:CAS:528:DC%2BD2cXlvFagu70%3D